Original Research

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, Sachs P

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:629-645

Published Date: 16 June 2014